4//SEC Filing
McManus Matthew 4
Accession 0001062993-25-014698
CIK 0000842023other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:28 PM ET
Size
22.9 KB
Accession
0001062993-25-014698
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
McManus Matthew
President - DGS
Transactions
- Exercise/Conversion
Common Stock
2025-08-15+2,637→ 5,615 total - Tax Payment
Common Stock
2025-08-15$53.60/sh−880$47,168→ 4,735 total - Exercise/Conversion
Restricted Stock Units
2025-08-15−2,637→ 5,275 total→ Common Stock (2,637 underlying) - Award
Performance Restricted Stock Units
2025-08-15+19,243→ 19,243 total→ Common Stock (19,243 underlying) - Award
Restricted Stock Units
2025-08-15+9,622→ 9,622 total→ Common Stock (9,622 underlying) - Award
Stock Option (Right to Buy)
2025-08-15+24,614→ 24,614 totalExercise: $53.60Exp: 2035-08-15→ Common Stock (24,614 underlying)
Holdings
- 15,902
Stock Option (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (15,902 underlying) - 7,951
Performance Stock Option (Right to Buy)
Exercise: $68.54Exp: 2031-02-01→ Common Stock (7,951 underlying) - 15,825
Performance Restricted Stock Units
→ Common Stock (15,825 underlying) - 2,888
Performance Restricted Stock Units
→ Common Stock (2,888 underlying) - 9,241
Restricted Stock Units
→ Common Stock (9,241 underlying) - 21,320
Stock Option (Right to Buy)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (21,320 underlying)
Footnotes (10)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F10]Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028.
- [F2]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F3]4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
- [F4]Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
- [F5]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F6]2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027.
- [F7]Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- [F8]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F9]3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028.
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001908268
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:28 PM ET
- Size
- 22.9 KB